Page last updated: 2024-08-25

fascaplysine and Melanoma

fascaplysine has been researched along with Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Collins, DM; Crown, J; Eustace, AJ; Mahgoub, T; O'Donovan, N; Walsh, N	1

Other Studies

1 other study(ies) available for fascaplysine and Melanoma

Article	Year
Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma. International journal of oncology, 2015, Volume: 47, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Indoles; Melanoma; Molecular Targeted Therapy; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Pyridines; Sulfonamides; Vemurafenib	2015

Article

Year

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma.

International journal of oncology, 2015, Volume: 47, Issue:3

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Indoles; Melanoma; Molecular Targeted Therapy; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Pyridines; Sulfonamides; Vemurafenib

2015